Assignee
PALATIN TECHNOLOGIES INC
US·57 granted patents·21 pending applications·577 citations·filing 1999–2022
Top patents by PatentIndex Score
78 records- 0193US7968548B2Melanocortin receptor-specific piperazine compounds with diamine groupsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 28, 2011·19 cites·16 claims
- 0292US7396814B2Metallopeptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jul 8, 2008·12 cites·12 claims
- 0392US6579968B1Compositions and methods for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2000·Granted Jun 17, 2003·84 cites·7 claims
- 0491US7342089B2Cyclic peptides for treatment for cachexiaPALATIN TECHNOLOGIES INC·Filed 2005·Granted Mar 11, 2008·21 cites·18 claims
- 0591US7176279B2Cyclic peptide compositions and methods for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2003·Granted Feb 13, 2007·28 cites·19 claims
- 0690US7897721B2Cyclic peptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2009·Granted Mar 1, 2011·5 cites·30 claims
- 0789US8877890B2Melanocortin-1 receptor-specific cyclic peptidesPALATIN TECHNOLOGIES INC·Filed 2013·Granted Nov 4, 2014·8 cites·27 claims
- 0889US7345144B2Cyclic peptides for treatment of cachexiaPALATIN TECHNOLOGIES INC·Filed 2005·Granted Mar 18, 2008·15 cites·16 claims
- 0989US6794489B2Compositions and methods for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2002·Granted Sep 21, 2004·49 cites·18 claims
- 1088US7795221B2Linear natriuretic peptide constructsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Sep 14, 2010·15 cites·13 claims
- 1188US7727991B2Substituted melanocortin receptor-specific single acyl piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 1, 2010·8 cites·15 claims
- 1288US7354923B2Piperazine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Apr 8, 2008·26 cites·50 claims
- 1388US7326707B2Bicyclic melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Feb 5, 2008·23 cites·56 claims
- 1487US11590209B2Use of bremelanotide in patients with controlled hypertensionPALATIN TECHNOLOGIES INC·Filed 2021·Granted Feb 28, 2023·2 cites·17 claims
- 1587US7732451B2Naphthalene-containing melanocortin receptor-specific small moleculePALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 8, 2010·6 cites·15 claims
- 1687US7718802B2Substituted melanocortin receptor-specific piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted May 18, 2010·6 cites·34 claims
- 1787US7235625B2Multiple agent therapy for sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 26, 2007·17 cites·22 claims
- 1886US8729224B2Melanocortin receptor-specific peptides for treatment of female sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2013·Granted May 20, 2014·7 cites·9 claims
- 1986US7709484B1Substituted melanocortin receptor-specific piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted May 4, 2010·8 cites·19 claims
- 2086US7456184B2Melanocortin receptor-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Nov 25, 2008·24 cites·15 claims
- 2186US7049398B1Melanocortin metallopeptide constructs, combinatorial libraries and applicationsPALATIN TECHNOLOGIES INC·Filed 2000·Granted May 23, 2006·16 cites·54 claims
- 2285US10711039B2Melanocortin receptor-specific peptide with C-terminal naphthylalaninePALATIN TECHNOLOGIES INC·Filed 2018·Granted Jul 14, 2020·1 cites·17 claims
- 2385US10017539B2Melanocortin-1 receptor-specific cyclic hexapeptidesPALATIN TECHNOLOGIES INC·Filed 2016·Granted Jul 10, 2018·3 cites·20 claims
- 2485US7727990B2Melanocortin receptor-specific piperazine and keto-piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 1, 2010·6 cites·20 claims
- 2584US9447148B2Melanocortin-1 receptor-specific cyclic peptidesPALATIN TECHNOLOGIES INC·Filed 2014·Granted Sep 20, 2016·4 cites·30 claims
- 2684US7795378B2Peptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Sep 14, 2010·5 cites·4 claims
- 2783US7964601B2Melanocortin receptor-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2008·Granted Jun 21, 2011·6 cites·17 claims
- 2883US7385025B2Metallopeptide compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 10, 2008·2 cites·10 claims
- 2983US6331285B1Structurally determined cyclic metallo-constructs and applicationsPALATIN TECHNOLOGIES INC·Filed 1999·Granted Dec 18, 2001·61 cites·16 claims
- 3082US7622440B2Cyclic natriuretic peptide constructsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Nov 24, 2009·6 cites·24 claims
- 3182US7473760B2Cyclic peptide compositions for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jan 6, 2009·16 cites·9 claims
- 3281US7754691B1Linear melanocortin receptor-specific peptides for cachexiaPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jul 13, 2010·3 cites·13 claims
- 3381US7655658B2Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted Feb 2, 2010·4 cites·15 claims
- 3481US7097824B2Tuftsin metallopeptide analogs and uses thereofPALATIN TECHNOLOGIES INC·Filed 2003·Granted Aug 29, 2006·8 cites·17 claims
- 3580US10106578B2Melanocortin-1 receptor-specific linear peptidesPALATIN TECHNOLOGIES INC·Filed 2017·Granted Oct 23, 2018·2 cites·7 claims
- 3680US7834017B2Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituentsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Nov 16, 2010·5 cites·10 claims
- 3780US7550602B1Small molecule compositions for sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 23, 2009·2 cites·9 claims
- 3880US7189755B2Pyrrolidine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Mar 13, 2007·9 cites·12 claims
- 3978US7807678B2Peptidomimetics of biologically active metallopeptidesPALATIN TECHNOLOGIES INC·Filed 2004·Granted Oct 5, 2010·8 cites·2 claims
- 4078US7417027B2Linear and cyclic melanocortin receptor-specific peptidesPALATIN TECHNOLOGIES INC·Filed 2004·Granted Aug 26, 2008·12 cites·8 claims
- 4178US2022362328A1Uses of bremelanotide in therapy for female sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4277US7307063B2Melanocortin metallopeptides for treatment of sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2003·Granted Dec 11, 2007·7 cites·12 claims
- 4376US10286034B2Uses of bremelanotide in therapy for female sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2017·Granted May 14, 2019·1 cites·17 claims
- 4476US7425608B2Method of making metallopeptidesPALATIN TECHNOLOGIES INC·Filed 2005·Granted Sep 16, 2008·1 cites·4 claims
- 4575US7964181B2Amino acid surrogates for peptidic constructsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Jun 21, 2011·1 cites·35 claims
- 4674US12459894B2Orally active melanocortin receptor-4 compoundsPALATIN TECHNOLOGIES INC·Filed 2022·Granted Nov 4, 2025·0 cites·7 claims
- 4774US11286280B2Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapyPALATIN TECHNOLOGIES INC·Filed 2020·Granted Mar 29, 2022·0 cites·10 claims
- 4874US7601753B2Pyrrolidine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Oct 13, 2009·1 cites·17 claims
- 4973US9580466B2Melanocortin-1 receptor-specific linear peptidesPALATIN TECHNOLOGIES INC·Filed 2014·Granted Feb 28, 2017·1 cites·5 claims
- 5072US9458201B2Melanocortin receptor-specific heptapeptidesPALATIN TECHNOLOGIES INC·Filed 2014·Granted Oct 4, 2016·0 cites·16 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PALATIN TECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →